Should I buy or sell Cooper Companies stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" COO shares. View COO analyst ratings or view top-rated stocks .

What is Cooper Companies' stock price target for 2024?

10 analysts have issued twelve-month price targets for Cooper Companies' stock. Their COO share price targets range from $88.75 to $125.00. On average, they predict the company's stock price to reach $109.48 in the next twelve months. This suggests a possible upside of 22.2% from the stock's current price. View analysts price targets for COO or view top-rated stocks among Wall Street analysts .

How have COO shares performed in 2024?

Cooper Companies' stock was trading at $94.61 at the start of the year. Since then, COO stock has decreased by 5.3% and is now trading at $89.58. View the best growth stocks for 2024 here .

Are investors shorting Cooper Companies?

Cooper Companies saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,180,000 shares, a decrease of 12.1% from the March 15th total of 2,480,000 shares. Based on an average trading volume of 1,110,000 shares, the short-interest ratio is presently 2.0 days. View Cooper Companies' Short Interest .

When is Cooper Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 30th 2024. View our COO earnings forecast .

How can I listen to Cooper Companies' earnings call?

Cooper Companies will be holding an earnings conference call on Thursday, May 30th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NASDAQ:COO) announced its quarterly earnings results on Thursday, February, 29th. The medical device company reported $0.85 earnings per share for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The medical device company earned $931.60 million during the quarter, compared to analyst estimates of $915.93 million. Cooper Companies had a net margin of 7.93% and a trailing twelve-month return on equity of 8.79%. The firm's quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.90 EPS. Read the conference call transcript .

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies declared a quarterly dividend on Wednesday, July 12th. Stockholders of record on Thursday, July 27th will be given a dividend of $0.0075 per share on Friday, August 11th. This represents a $0.03 dividend on an annualized basis and a dividend yield of 0.03%. The ex-dividend date of this dividend is Wednesday, July 26th. Read our dividend analysis for COO .

Is Cooper Companies a good dividend stock?

Cooper Companies (NASDAQ:COO) pays an annual dividend of $0.01 per share and currently has a dividend yield of 0.01%. The dividend payout ratio is 0.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, COO will have a dividend payout ratio of 0.26% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for COO .

What ETFs hold Cooper Companies' stock?

ETFs with the largest weight of Cooper Companies (NASDAQ:COO) stock in their portfolio include Simplify Health Care ETF (PINK) , Motley Fool Mid-Cap Growth ETF (TMFM) , Nuveen ESG Mid-Cap Growth ETF (NUMG) , BlackRock Future Health ETF (BMED) , VictoryShares Nasdaq Next 50 ETF (QQQN) , First Trust Indxx Medical Devices ETF (MDEV) , Harbor Health Care ETF (MEDI) and Invesco ESG NASDAQ Next Gen 100 ETF (QQJG) .

When did Cooper Companies' stock split?

Cooper Companies shares split before market open on Tuesday, February 20th 2024. The 4-1 split was announced on Tuesday, February 20th 2024. The newly created shares were payable to shareholders after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of 3.500-3.580 for the period, compared to the consensus EPS estimate of 3.460. The company issued revenue guidance of $3.8 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion.

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (0.64%), Laurus Investment Counsel Inc. (0.04%), WD Rutherford LLC (0.02%), Czech National Bank (0.02%), Gulf International Bank UK Ltd (0.01%) and Mirador Capital Partners LP (0.01%). Insiders that own company stock include Agostino Ricupati , Brian G Andrews , Daniel G Mcbride , Gary S Petersmeyer , Gerard H Warner III , Jody S Lindell and Robert S Weiss . View institutional ownership trends .

How do I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Cooper Companies have any subsidiaries?

The following companies are subsidiares of Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP. Read More

NASDAQ:COO

Cooper Companies (COO) Stock Price, News & Analysis

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)

Free COO Stock Alerts

$90.78

+0.92 (+1.02%)

(As of 12:09 PM ET)

Compare

Today's Range: $89.41
▼
$90.81
50-Day Range: $89.86
▼
$102.77
52-Week Range: $75.93
▼
$104.07

Volume: 254,937 shs
Average Volume: 1.08 million shs
Market Capitalization: $18.04 billion

P/E Ratio: 62.07
Dividend Yield: 0.01%
Price Target: $109.48

Get Cooper Companies alerts:

Cooper Companies MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.80 Rating Score
Upside/Downside: 21.2% Upside
$109.48 Price Target
Short Interest: Healthy
1.10% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.14
Based on 10 Articles This Week
Insider Trading: Selling Shares
$5.62 M Sold Last Quarter
Proj. Earnings Growth: 11.43%
From $3.50 to $3.90 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.67 out of 5 stars

Medical Sector

216th out of 914 stocks

Ophthalmic Goods Industry

2nd out of 7 stocks

3.4

Analyst's Opinion

Consensus Rating
Cooper Companies has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Cooper Companies has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
1.10% of the outstanding shares of Cooper Companies have been sold short.
Short Interest Ratio / Days to Cover
Cooper Companies has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cooper Companies has recently decreased by 12.10%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
Cooper Companies has a dividend yield of 0.01%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Cooper Companies does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Cooper Companies is 0.68%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Cooper Companies will have a dividend payout ratio of 0.26% next year. This indicates that Cooper Companies will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for COO.

1.2

News and Social Media Coverage

News Sentiment
Cooper Companies has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Cooper Companies this week, compared to 10 articles on an average week.
Search Interest
Only 7 people have searched for COO on MarketBeat in the last 30 days. This is a decrease of -70% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Cooper Companies to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cooper Companies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,624,614.00 in company stock.
Percentage Held by Insiders
Only 2.00% of the stock of Cooper Companies is held by insiders.
Percentage Held by Institutions
Only 24.39% of the stock of Cooper Companies is held by institutions.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Cooper Companies are expected to grow by 11.43% in the coming year, from $3.50 to $3.90 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cooper Companies is 61.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.99.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cooper Companies is 61.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 187.06.
Price to Earnings Growth Ratio
Cooper Companies has a PEG Ratio of 2.30. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Cooper Companies has a P/B Ratio of 2.37. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

Click here to learn more while there’s still time.

About Cooper Companies Stock (NASDAQ:COO)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

COO Stock News Headlines

April 10, 2024 | marketbeat.com

Thai prime minister unveils details of a $13.5 billion digital money handout plan

Thailand’s Prime Minister Srettha Thavisin has revealed details of his government’s plan to stimulate the economy by giving digital cash handouts of 10,000 baht ($275) to an estimated qualifying 50 million Thais for spending at their local businesses

April 8, 2024 | marketbeat.com

Culinary diplomacy: The internet is obsessed with what Janet Yellen eats in China

Ever since she ate mushrooms that can have psychedelic effects in Beijing last July, Janet Yellen has united Americans and Chinese in wanting to know what she will eat next

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

March 21, 2024 | insidertrades.com

The Cooper Companies, Inc. (NASDAQ:COO) CAO Agostino Ricupati Sells 54,724 Shares

April 17, 2024 | americanbankingnews.com

Cooper Companies (NASDAQ:COO) Stock Price Passes Above 200-Day Moving Average of $90.92

April 15, 2024 | msn.com

Cooper Companies (NASDAQ:COO): Analysts Are Bullish on this MedTech S&P 500 Stock

April 13, 2024 | ca.news.yahoo.com

Open Source: Gov. Cooper talks Toyota lesson | IBM’s RTP anniversary | IKEA gap

April 12, 2024 | msn.com

Gov. Roy Cooper touts North Carolina 'on the global stage' with visit by Japan's Prime Minister

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

April 12, 2024 | msn.com

Open Source: Gov. Cooper talks lessons from initial Toyota miss and how NC courts Japan

April 12, 2024 | yahoo.com

Open Source: Gov. Cooper talks initial Toyota failure | IBM’s RTP anniversary | IKEA gap

April 12, 2024 | msn.com

North Carolina governor welcomes historic visitor at mansion: Japan's Prime Minister Fumio Kishida

April 12, 2024 | msn.com

Japanese companies make huge investments in North Carolina ahead of prime minister's visit

April 12, 2024 | foxnews.com

Japanese PM Kishida to visit North Carolina governor's mansion in historic first

April 11, 2024 | msn.com

Fujifilm Diosynth to create 680 jobs, invest additional $1.2B in Holly Springs

April 10, 2024 | msn.com

4-star WR Cooper Perry sets commitment date

April 10, 2024 | msn.com

Breaking Down Cooper DeJean's Mind-Blowing Pro Day Workout

April 9, 2024 | msn.com

Cooper's visit with Japan's Kishida could coincide with major jobs announcement

April 9, 2024 | forbes.com

How The "Pretty Lonesome" Podcast Host Earned 7-Figures And Inked A Deal With Alex Cooper

April 9, 2024 | americanbankingnews.com

The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Recommendation of "Moderate Buy" from Analysts

April 4, 2024 | investorplace.com

Double Your Shares, Double Your Gains: 3 Stock Split Plays for 2024

March 31, 2024 | msn.com

Bradley Cooper and Gigi Hadid 'itching' to introduce their children as 'they plan a future together'

March 29, 2024 | msn.com

Nottingham Forest reveal £155.7m transfers update and Steve Cooper exit detail in latest accounts

March 28, 2024 | bizjournals.com

BRED 2024 Residential Dealmakers: David da Ponte-Cooper with Sowell Realtors

March 28, 2024 | msn.com

J.W. Cooper building condemned, collapse threatens vital food bank operations

March 27, 2024 | msn.com

2025 Mini Cooper S Hardtop Revealed in NYC

March 27, 2024 | markets.businessinsider.com

Buy Rating Affirmed for Cooper Companies, Inc. on Optimistic FY2024 Outlook and Strategic Market Positioning

See More Headlines

Receive COO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/29/2024
Today: 4/18/2024
Next Earnings (Confirmed): 5/30/2024
Fiscal Year End: 10/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Ophthalmic goods
Sub-Industry: Health Care Supplies
Current Symbol: NASDAQ:COO
Previous Symbol: NYSE:COO
CUSIP: 21664840
CIK: 711404
Web: www.coopercos.com
Phone: (925) 460-3600
Fax: 925-460-3649
Employees: 15,000
Year Founded: 1958

Price Target and Rating

Average Stock Price Target: $109.48
High Stock Price Target: $125.00
Low Stock Price Target: $88.75
Potential Upside/Downside: +21.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.80
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.4625
Trailing P/E Ratio: 61.44
Forward P/E Ratio: 25.67
P/E Growth: 2.3
Net Income: $294.20 million
Net Margins: 7.93%
Pretax Margin: 11.20%
Return on Equity: 8.79%
Return on Assets: 5.65%

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 1.86
Quick Ratio: 1.08

Sales & Book Value

Annual Sales: $3.59 billion
Price / Sales: 4.97
Cash Flow: $5.04 per share
Price / Cash Flow: 17.83
Book Value: $38.12 per share
Price / Book: 2.36

Miscellaneous

Outstanding Shares: 198,760,000
Free Float: 194,781,000
Market Cap: $17.86 billion
Optionable: Optionable
Beta: 0.94

Social Links

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Albert G. White III (Age 54)
President, CEO & Non-Independent Director
Comp: $2.91M
Mr. Brian G. Andrews (Age 45)
Executive VP, CFO & Treasurer
Comp: $1.22M
Mr. Daniel G. McBride Esq. (Age 60)
Executive VP & COO
Comp: $1.6M
Ms. Holly R. Sheffield (Age 53)
President of CooperSurgical, Inc.
Comp: $1.1M
Mr. Gerard H. Warner III (Age 59)
President of CooperVision, Inc.
Comp: $1M
Mr. Agostino Ricupati (Age 57)
Senior VP & Chief Accounting Officer
Comp: $670.71k
Mr. Kim Duncan
Vice President of Investor Relations & Risk Management
Mr. Nicholas S. Khadder (Age 50)
General Counsel & Corporate Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

COO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cooper Companies stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" COO shares.
View COO analyst ratings or view top-rated stocks.
What is Cooper Companies' stock price target for 2024?: 10 analysts have issued twelve-month price targets for Cooper Companies' stock. Their COO share price targets range from $88.75 to $125.00. On average, they predict the company's stock price to reach $109.48 in the next twelve months. This suggests a possible upside of 22.2% from the stock's current price.
View analysts price targets for COO or view top-rated stocks among Wall Street analysts.
How have COO shares performed in 2024?: Cooper Companies' stock was trading at $94.61 at the start of the year. Since then, COO stock has decreased by 5.3% and is now trading at $89.58.
View the best growth stocks for 2024 here.
Are investors shorting Cooper Companies?: Cooper Companies saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,180,000 shares, a decrease of 12.1% from the March 15th total of 2,480,000 shares. Based on an average trading volume of 1,110,000 shares, the short-interest ratio is presently 2.0 days.
View Cooper Companies' Short Interest.
When is Cooper Companies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 30th 2024.
View our COO earnings forecast.
How can I listen to Cooper Companies' earnings call?: Cooper Companies will be holding an earnings conference call on Thursday, May 30th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Cooper Companies' earnings last quarter?: The Cooper Companies, Inc. (NASDAQ:COO) announced its quarterly earnings results on Thursday, February, 29th. The medical device company reported $0.85 earnings per share for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The medical device company earned $931.60 million during the quarter, compared to analyst estimates of $915.93 million. Cooper Companies had a net margin of 7.93% and a trailing twelve-month return on equity of 8.79%. The firm's quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.90 EPS.
Read the conference call transcript.
How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?: Cooper Companies declared a quarterly dividend on Wednesday, July 12th. Stockholders of record on Thursday, July 27th will be given a dividend of $0.0075 per share on Friday, August 11th. This represents a $0.03 dividend on an annualized basis and a dividend yield of 0.03%. The ex-dividend date of this dividend is Wednesday, July 26th.
Read our dividend analysis for COO.

Is Cooper Companies a good dividend stock?: Cooper Companies (NASDAQ:COO) pays an annual dividend of $0.01 per share and currently has a dividend yield of 0.01%. The dividend payout ratio is 0.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, COO will have a dividend payout ratio of 0.26% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for COO.
What ETFs hold Cooper Companies' stock?: ETFs with the largest weight of Cooper Companies (NASDAQ:COO) stock in their portfolio include Simplify Health Care ETF (PINK), Motley Fool Mid-Cap Growth ETF (TMFM), Nuveen ESG Mid-Cap Growth ETF (NUMG), BlackRock Future Health ETF (BMED), VictoryShares Nasdaq Next 50 ETF (QQQN), First Trust Indxx Medical Devices ETF (MDEV), Harbor Health Care ETF (MEDI) and Invesco ESG NASDAQ Next Gen 100 ETF (QQJG).
When did Cooper Companies' stock split?: Cooper Companies shares split before market open on Tuesday, February 20th 2024. The 4-1 split was announced on Tuesday, February 20th 2024. The newly created shares were payable to shareholders after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.
What guidance has Cooper Companies issued on next quarter's earnings?: Cooper Companies updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of 3.500-3.580 for the period, compared to the consensus EPS estimate of 3.460. The company issued revenue guidance of $3.8 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion.
Who are Cooper Companies' major shareholders?: Cooper Companies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (0.64%), Laurus Investment Counsel Inc. (0.04%), WD Rutherford LLC (0.02%), Czech National Bank (0.02%), Gulf International Bank UK Ltd (0.01%) and Mirador Capital Partners LP (0.01%). Insiders that own company stock include Agostino Ricupati, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Gerard H Warner III, Jody S Lindell and Robert S Weiss.
View institutional ownership trends.
How do I buy shares of Cooper Companies?: Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Cooper Companies have any subsidiaries?: The following companies are subsidiares of Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.
Read More

This page (NASDAQ:COO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cooper Companies (COO) Stock Price, News & Analysis

Cooper Companies MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Cooper Companies Stock (NASDAQ:COO)

COO Stock Price History

COO Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

COO Stock Analysis - Frequently Asked Questions

Overall MarketRank^™